-
Je něco špatně v tomto záznamu ?
Biochemical evidence for conformational variants in the anti-viral and pro-metastatic protein IFITM1
M. Nekulová, M. Wyszkowska, N. Friedlová, L. Uhrík, F. Zavadil Kokáš, V. Hrabal, L. Hernychová, B. Vojtěšek, TR. Hupp, MR. Szymański
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
38379409
DOI
10.1515/hsz-2023-0327
Knihovny.cz E-zdroje
- MeSH
- antivirové látky farmakologie chemie metabolismus MeSH
- diferenciační antigeny * metabolismus chemie MeSH
- konformace proteinů * MeSH
- lidé MeSH
- rekombinantní proteiny chemie izolace a purifikace metabolismus biosyntéza MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Interferon induced transmembrane proteins (IFITMs) play a dual role in the restriction of RNA viruses and in cancer progression, yet the mechanism of their action remains unknown. Currently, there is no data about the basic biochemical features or biophysical properties of the IFITM1 protein. In this work, we report on description and biochemical characterization of three conformational variants/oligomeric species of recombinant IFITM1 protein derived from an Escherichia coli expression system. The protein was extracted from the membrane fraction, affinity purified, and separated by size exclusion chromatography where two distinct oligomeric species were observed in addition to the expected monomer. These species remained stable upon re-chromatography and were designated as "dimer" and "oligomer" according to their estimated molecular weight. The dimer was found to be less stable compared to the oligomer using circular dichroism thermal denaturation and incubation with a reducing agent. A two-site ELISA and HDX mass spectrometry suggested the existence of structural motif within the N-terminal part of IFITM1 which might be significant in oligomer formation. Together, these data show the unusual propensity of recombinant IFITM1 to naturally assemble into very stable oligomeric species whose study might shed light on IFITM1 anti-viral and pro-oncogenic functions in cells.
Department of Experimental Biology Faculty of Science Masaryk University 625 00 Brno Czech Republic
Institute of Genetics and Molecular Medicine University of Edinburgh EH4 2XR Edinburgh UK
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24013864
- 003
- CZ-PrNML
- 005
- 20240905133816.0
- 007
- ta
- 008
- 240725s2024 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1515/hsz-2023-0327 $2 doi
- 035 __
- $a (PubMed)38379409
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Nekulová, Marta $u Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic $1 https://orcid.org/0000000164042566
- 245 10
- $a Biochemical evidence for conformational variants in the anti-viral and pro-metastatic protein IFITM1 / $c M. Nekulová, M. Wyszkowska, N. Friedlová, L. Uhrík, F. Zavadil Kokáš, V. Hrabal, L. Hernychová, B. Vojtěšek, TR. Hupp, MR. Szymański
- 520 9_
- $a Interferon induced transmembrane proteins (IFITMs) play a dual role in the restriction of RNA viruses and in cancer progression, yet the mechanism of their action remains unknown. Currently, there is no data about the basic biochemical features or biophysical properties of the IFITM1 protein. In this work, we report on description and biochemical characterization of three conformational variants/oligomeric species of recombinant IFITM1 protein derived from an Escherichia coli expression system. The protein was extracted from the membrane fraction, affinity purified, and separated by size exclusion chromatography where two distinct oligomeric species were observed in addition to the expected monomer. These species remained stable upon re-chromatography and were designated as "dimer" and "oligomer" according to their estimated molecular weight. The dimer was found to be less stable compared to the oligomer using circular dichroism thermal denaturation and incubation with a reducing agent. A two-site ELISA and HDX mass spectrometry suggested the existence of structural motif within the N-terminal part of IFITM1 which might be significant in oligomer formation. Together, these data show the unusual propensity of recombinant IFITM1 to naturally assemble into very stable oligomeric species whose study might shed light on IFITM1 anti-viral and pro-oncogenic functions in cells.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a diferenciační antigeny $x metabolismus $x chemie $7 D000943
- 650 12
- $a konformace proteinů $7 D011487
- 650 _2
- $a rekombinantní proteiny $x chemie $x izolace a purifikace $x metabolismus $x biosyntéza $7 D011994
- 650 _2
- $a antivirové látky $x farmakologie $x chemie $x metabolismus $7 D000998
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Wyszkowska, Marta $u Structural Biology Laboratory, Intercollegiate Faculty of Biotechnology of University of Gdansk and Medical University of Gdansk, University of Gdansk, 80-307 Gdansk, Poland
- 700 1_
- $a Friedlová, Nela $u Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic $u Department of Experimental Biology, Faculty of Science, Masaryk University, 625 00 Brno, Czech Republic
- 700 1_
- $a Uhrík, Lukáš $u Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic
- 700 1_
- $a Zavadil Kokáš, Filip $u Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic
- 700 1_
- $a Hrabal, Václav $u Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic $u Department of Experimental Biology, Faculty of Science, Masaryk University, 625 00 Brno, Czech Republic
- 700 1_
- $a Hernychová, Lenka $u Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic
- 700 1_
- $a Vojtěšek, Bořivoj $u Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic
- 700 1_
- $a Hupp, Ted R $u Institute of Genetics and Molecular Medicine, University of Edinburgh, EH4 2XR Edinburgh, UK
- 700 1_
- $a Szymański, Michał R $u Structural Biology Laboratory, Intercollegiate Faculty of Biotechnology of University of Gdansk and Medical University of Gdansk, University of Gdansk, 80-307 Gdansk, Poland
- 773 0_
- $w MED00005521 $t Biological chemistry $x 1437-4315 $g Roč. 405, č. 5 (2024), s. 311-324
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38379409 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905133810 $b ABA008
- 999 __
- $a ok $b bmc $g 2143587 $s 1225730
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 405 $c 5 $d 311-324 $e 20240222 $i 1437-4315 $m Biological chemistry $n Biol Chem $x MED00005521
- LZP __
- $a Pubmed-20240725